Michael Carducci, MD
Medical Oncology · Baltimore, MDNPI 1952369977
Payments from drug & device makers
Across 338 payments — averaging $14,188 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1.9M
- Merck$1.4M
- Pfizer$617K
- EMD Serono, Inc.$440K
- Astrazeneca UK Limited$141K
- Bristol Myers Squibb$73K
- plus $200K from 8 others
Across 3 payments — averaging $1600.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 27 | $1,945,215 |
| Merck | 142 | $1,379,951 |
| Pfizer | 40 | $616,673 |
| EMD Serono, Inc. | 77 | $439,558 |
| Astrazeneca UK Limited | 11 | $140,820 |
| Bristol Myers Squibb | 4 | $73,467 |
| AstraZeneca | 11 | $68,652 |
| Gilead | 5 | $61,270 |
| Exelixis Inc. | 9 | $38,438 |
| Genentech, Inc. | 3 | $20,971 |
| Astellas Pharma US Inc | 6 | $6,792 |
| Sanofi | 1 | $3,605 |
| Eli Lilly | 1 | $37 |
| F. Hoffmann-la Roche AG | 1 | $22 |
How this compares
$4,795,472 in reported general payments places this provider in the 90th percentile of 180 medical oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Baltimore
- Dung leBaltimore$18.7M
- Stephanie GaillardBaltimore$12.2M
- Ashraf BadrosBaltimore$7.2M
- Patrick BrownBaltimore$6.6M
- Nilofer AzadBaltimore$6.5M
- Jean Hoffman-CensitsBaltimore$5.7M
- Ranee MehraBaltimore$5.2M
- Tanguy Lim-SeiwertBaltimore$4.6M
- Mark LevisBaltimore$4.2M
- Arif HussainBaltimore$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.